Innate Cellular Immunity in Newly Diagnosed Pulmonary Tuberculosis Patients and During Chemotherapy

por Victory Fabian Edem MSc, Ganiyu Olatunbosun Arinola
Publicado 2016

Comment on “Correlation of L-asp Activity, Anti-L-asp Antibody, asn and gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL”

por Wing H. Tong MD, PhD, MSc
Publicado 2021

Functional 2D MXene Inks for Wearable Electronics

por Bouchaib Zazoum, Abdel Bachri, Jamal Nayfeh
Publicado 2021

Patients With Coronavirus Disease 2019 Requiring Invasive Mechanical Ventilation in Mexico in the First, Second, and Exponential Growth Phase of the Third Wave of the Coronavirus D...

por Silvio A. Ñamendys-Silva, MD, MSc, FCCP, FCCM
Publicado 2021

A Modified Delphi Process to Prioritize Experiences and Guidance Related to ICU Restricted Visitation Policies During the Coronavirus Disease 2019 Pandemic

por Kirsten M. Fiest, PhD, Karla D. Krewulak, PhD, Kira Makuk, BHSc, Natalia Jaworska, MD, MSc, Laura Hernández, BA, Sean M. Bagshaw, MD, MSc, Karen E. Burns, MD, MSc, Deborah J. Cook, MD, MSc, Christopher J. Doig, MD, MSc, Alison Fox-Robichaud, MD, MSc, Robert A. Fowler, MD, MSc, Michelle E. Kho, PT, PhD, Ken Kuljit S. Parhar, MD, MSc, Oleksa G. Rewa, MD, MSc, Bram Rochwerg, MD, MSc, Bonnie G. Sept, Andrea Soo, PhD, Sean Spence, MD, Andrew West, EdD, Henry T. Stelfox, MD, PhD, Jeanna Parsons Leigh, PhD, for the Canadian Critical Care Trials Group, Kusum Menon, Vazquez Grande, Mark Duffet, Jennifer Foster, Dominique Piquette, Nicole Zytaruk, Sylvie Debigaré, Srinivas Murthy, Danaë Tassy, Sangeeta Mehta
Publicado 2021

Hypophosphatemic Rickets in Colombia: A Prevalence-Estimation Model in Rare Diseases. 2018

por Jancy Andrea Huertas-Quintero, MD, MSc, Natalia Losada-Trujillo, MD, Diego Alberto Cuellar-Ortiz, MSc, Harvy Mauricio Velasco-Parra, MD
Publicado 2022